Excitingly, we observed that PP2A and GSK3 inhibition can rescue mitochondrial transport deficits in FUS-ALS patient iPSC-sMNs, and kinesin-1 appears as an intermediate regulator of this cascade. This evidence concerns the gene KIF5C and amyotrophic lateral sclerosis.